WuXi Biologics Achieves A List Recognition from CDP for Supplier Engagement

WuXi Biologics Recognized by CDP for Supplier Engagement Excellence

WuXi Biologics, a prominent global Contract Research, Development, and Manufacturing Organization (CRDMO), has been honored with a spot on the CDP Supplier Engagement Assessment (SEA) A List. This recognition from the CDP, which is a leading environmental non-profit organization, highlights the company’s commitment to climate-related issues within its supply chain. The A List is reserved for companies that score exceptionally high in regards to their leadership on supply chain engagement concerning climate change and efforts toward creating a sustainable economy.

In 2024, approximately 25,000 companies from across the globe contributed environmental data to CDP, representing about two-thirds of the total global market value. WuXi Biologics was distinguished for its efforts in several key areas, including governance, business strategy, target setting, Scope 3 emissions reporting, and its risk management methodologies. In addition to this recognition, WuXi Biologics has also secured positions on the CDP Water Security A List and has maintained high-level Climate Change Leadership scores for two consecutive years.

A significant part of WuXi Biologics’ strategy aligns with the Science Based Target initiative (SBTi). The organization’s integrated approach focuses on tackling climate change through clear measurable goals and a structured roadmap. Notably, the company achieved a notable 30% reduction in greenhouse gas emissions (Scope 1 and Scope 2) in 2024, using 2020 as the baseline year. Looking ahead, WuXi Biologics has set an ambitious target of achieving net-zero emissions across its operations by the year 2050.

Beyond its internal climate initiatives, WuXi Biologics actively collaborates with its suppliers, striving for comprehensive sustainable supply chain management. This includes tracking Scope 3 emissions data and engaging suppliers effectively to promote their sustainability commitments, ensuring a positive ripple effect throughout the value chain.

Dr. Chris Chen, the CEO of WuXi Biologics and the Chairman of its ESG Committee, expressed his enthusiasm regarding this recent recognition: “We are very pleased to be named to CDP's A List for its Supplier Engagement Assessment, an acknowledgment that further inspires our steadfast dedication to driving sustainability.” Dr. Chen reiterated WuXi Biologics' role as a key player in the green CRDMO sphere, emphasizing their commitment to providing excellence in environmental, social, and governance (ESG) practices.

WuXi Biologics’ dedication to sustainability is not only demonstrated through its recognition from CDP but is also reflected in various other esteemed accolades. The organization holds an MSCI AAA rating, has been awarded an EcoVadis Platinum Medal, and is listed in the Dow Jones Sustainability Indices (DJSI) due to its outstanding performance in sustainability-driven initiatives. Their commitment to ethical practices has earned them recognition as a top-rated company in terms of ESG by Sustainalytics, an achievement upheld for five consecutive years.

Furthermore, WuXi Biologics is a proactive participant in global sustainability initiatives, being an active member of both the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI). The company’s approach to sustainability serves as a pillar for long-term growth, with green technological innovations leading the way in providing advanced CRDMO solutions to partners worldwide.

The global footprint of WuXi Biologics includes over 12,000 professionals situated in China, the United States, Ireland, Germany, and Singapore. This widespread workforce enhances its capability to support multiple integrated client projects, aligning closely with its mission to improve healthcare outcomes through biologics development and manufacturing.

For further insights and information about WuXi Biologics and its ongoing sustainability efforts, visit www.wuxibiologics.com.